Approval · Notice of Compliance 5358 · 2004
GEN-CLINDAMYCIN: Notice of Compliance 5358
Issued September 13, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5358
- Date
- September 13, 2004
- Company
- Genpharm Inc.Etobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antibiotic
- Canadian reference product
- DALACIN C (Pharmacia & Upjohn Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GEN-CLINDAMYCIN | 02258331 | Cancelled Post Market |
| GEN-CLINDAMYCIN | 02258358 | Cancelled Post Market |
Medicinal ingredients
- CLINDAMYCIN HCL 150 MG per CAP
- CLINDAMYCIN HCL 300 MG per CAP